1.75 mg or 2 mg injections) or in some cases slightly higher doses (reports of 4 mg or even 6 mg have been studied in ED trials)
Packer recently proposed an intriguing hypothesis that DPP-4 inhibitors potentiate some endogenous peptides, such as stromal cell-derived factor-1, in addition to activation of GLP-1, and that unfavorable effects of those peptides on CV parameters (e.g., inflammation, fibrosis, plaque growth, and sympathetic activation) could prevail against the CV protective effects of GLP-1, possibly leading to worsened CV complications and HF [36, 37]
HbA1c reductions were 1.7% at 4 mg, 2.0% at 9 mg, and 1.9% at 12 mg, compared with 0.8% on placebo
Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4MD2 complex
Back Gilbert, B, Rosenthal, D (5 March 2024) 'The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)', Acquired podcast, ACQ2 Episode
Avoid rubbing the injection site